Bloodstream Infection
0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
ExThera MedicalCA - Martinez
1 programSeraph 100,The Microbind Affinity Blood FilterN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Rochecobas eplex multiplex PCR
ExThera MedicalSeraph 100,The Microbind Affinity Blood Filter
Clinical Trials (2)
Total enrollment: 432 patients across 2 trials
The Clinical Impact of Cobas® Eplex Blood Culture Panels for the Diagnosis of Bacteremia and Fungemia
Start: Nov 2024Est. completion: Dec 2025200 patients
N/ARecruiting
Reduction of Pathogen Load From the Blood in Septic Patients With Suspected, Life-threatening Bloodstream Infection
Start: Aug 2020Est. completion: Aug 2022232 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 432 patients
2 companies competing in this space